These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10970221)

  • 1. Microbiology. A weak link in TB bacterium is found.
    Helmuth L
    Science; 2000 Aug; 289(5482):1123-5. PubMed ID: 10970221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid lunch for persistent pathogen.
    Bishai W
    Nature; 2000 Aug; 406(6797):683-5. PubMed ID: 10963578
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting isocitrate lyase for the treatment of latent tuberculosis.
    Bhusal RP; Bashiri G; Kwai BXC; Sperry J; Leung IKH
    Drug Discov Today; 2017 Jul; 22(7):1008-1016. PubMed ID: 28458043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis.
    Sharma V; Sharma S; Hoener zu Bentrup K; McKinney JD; Russell DG; Jacobs WR; Sacchettini JC
    Nat Struct Biol; 2000 Aug; 7(8):663-8. PubMed ID: 10932251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternate pathway to ascorbate induced inhibition of Mycobacterium tuberculosis.
    Shukla H; Khan SR; Shukla R; Krishnan MY; Akhtar MS; Tripathi T
    Tuberculosis (Edinb); 2018 Jul; 111():161-169. PubMed ID: 30029903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence.
    Muñoz-Elías EJ; McKinney JD
    Nat Med; 2005 Jun; 11(6):638-44. PubMed ID: 15895072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies.
    Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effects of 10-23 deoxyribozyme targeting ICL gene on the expression of isocitrate lyase and the infection of Mycobacterium tuberculosis in macrophages].
    Li JM; Li N; Zhu DY; Yi ZJ; Liu YH; Yang C; He YL
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):531-5. PubMed ID: 17074266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiology. TB--a new target, a new drug.
    Cole ST; Alzari PM
    Science; 2005 Jan; 307(5707):214-5. PubMed ID: 15653490
    [No Abstract]   [Full Text] [Related]  

  • 11. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis.
    Nandakumar M; Nathan C; Rhee KY
    Nat Commun; 2014 Jun; 5():4306. PubMed ID: 24978671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysine succinylation of Mycobacterium tuberculosis isocitrate lyase (ICL) fine-tunes the microbial resistance to antibiotics.
    Zhou M; Xie L; Yang Z; Zhou J; Xie J
    J Biomol Struct Dyn; 2017 Apr; 35(5):1030-1041. PubMed ID: 27023679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isocitrate lyase: a potential target for anti-tubercular drugs.
    Sharma R; Das O; Damle SG; Sharma AK
    Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):114-23. PubMed ID: 23506018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNAzymes targeting the icl gene inhibit ICL expression and decrease Mycobacterium tuberculosis survival in macrophages.
    Li J; Zhu D; Yi Z; He Y; Chun Y; Liu Y; Li N
    Oligonucleotides; 2005; 15(3):215-22. PubMed ID: 16201909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism-based inactivator of isocitrate lyases 1 and 2 from
    Pham TV; Murkin AS; Moynihan MM; Harris L; Tyler PC; Shetty N; Sacchettini JC; Huang HL; Meek TD
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7617-7622. PubMed ID: 28679637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of Anti-mycobacterial Phytochemical Compounds for Potential Inhibitors against Mycobacterium Tuberculosis Isocitrate Lyase.
    Tiwari A; Kumar A; Srivastava G; Sharma A
    Curr Top Med Chem; 2019; 19(8):600-608. PubMed ID: 30836915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism-Based Inactivation of
    Mellott DM; Torres D; Krieger IV; Cameron SA; Moghadamchargari Z; Laganowsky A; Sacchettini JC; Meek TD; Harris LD
    J Am Chem Soc; 2021 Oct; 143(42):17666-17676. PubMed ID: 34664502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus.
    Shukla H; Kumar V; Singh AK; Rastogi S; Khan SR; Siddiqi MI; Krishnan MY; Akhtar MS
    Int J Biol Macromol; 2015; 78():137-41. PubMed ID: 25869309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.
    McKinney JD; Höner zu Bentrup K; Muñoz-Elías EJ; Miczak A; Chen B; Chan WT; Swenson D; Sacchettini JC; Jacobs WR; Russell DG
    Nature; 2000 Aug; 406(6797):735-8. PubMed ID: 10963599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shortening the treatment of tuberculosis.
    Mitchison DA
    Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.